PFM Health Sciences’s Natera NTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-22,077
Closed -$5.99M – 111
2026
Q2
$5.99M Sell
22,077
-37,927
-63% -$8.09M 0.51% 63
2026
Q1
$12M Buy
+60,004
New +$12.9M 1.09% 28
2025
Q4
– Sell
-115,596
Closed -$18.6M – 97
2025
Q3
$18.6M Buy
115,596
+14,346
+14% +$2.27M 1.43% 21
2025
Q2
$17.1M Buy
+101,250
New +$15.8M 1.46% 22

Other funds holding NTRA

PFM Health Sciences's NTRA Position: Q3 2026 in Review

PFM Health Sciences sold out of Natera (NTRA) in Q3 2026, closing a stake of 22,077 shares — an estimated $5.99M sold.

PFM Health Sciences first reported a position in NTRA in Q2 2025 and held it in 4 quarters. The position peaked at $18.6M in Q3 2025. 945 funds tracked by Wall St. Rank hold NTRA as of Q3 2026.

  • PFM Health Sciences reported no remaining Natera position as of Q3 2026 after selling out during the quarter.
  • PFM Health Sciences sold 22,077 Natera shares in Q3 2026, an estimated $5.99M.
  • PFM Health Sciences first reported a position in Natera in Q2 2025 and held it in 4 quarters.
  • PFM Health Sciences's Natera position peaked at $18.6M in Q3 2025.
  • 945 funds tracked by Wall St. Rank held Natera as of Q3 2026.

Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.